PTPN2 and adoptive T cell immunotherapy
This project will determine whether the immune response to tumours can be enhanced by targeting an inhibitory molecule known as PTPN2. The results will lead to a new and more effective approach for cancer treatment.
Dr Florian Wiede
Cancer Council Research Grant
Monash University, Department of Biochemistry and Molecular Biology
$100,000 pa for three years